Iovance Biotherapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
29.02.24
/
50%
€14.52
Target price
28.02.25
€19.38
Performance (%)
-41.29%
Price
26.07.24
€8.52
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc. is performing very badly with a performance of -41.29%. This prediction currently runs until 28.02.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Iovance Biotherapeutics Inc. | 16.416% | 16.416% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $19.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
20.02.24
20.02.24
€17.55
20.02.25
20.02.25
-27.76%
26.07.24
26.07.24
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.05
20.11.23
20.11.23
€10.98
20.11.24
20.11.24
68.79%
26.07.24
26.07.24